This month's Master Class webinar will focus on the evolving oncology market access landscape and its disruptors, including payer control, patient behavior, and practice economics.

Key Takeaways:

• Payer control is more challenging, especially for oral oncolytics
• Patients are demonstrating consistent abandonment behaviors despite significant support program investments from manufacturers
• The IRA will have an impact on oncology in-line and pipeline assets, though the degree of impact may be variable

Speakers:

Jin Yang
Principal, Market Access Strategy Consulting, IQVIA

Jeff Thiesen
Managing Principal, Market Access Strategy Consulting, IQVIA